Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07464158

WRITE: Written Imaginal Thinking Exercise Study

Conditions: Anxiety, Stress, Social Anxiety

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 353
Sponsor: University of Colorado, Boulder

Location: University of Colorado Boulder Boulder Colorado

Summary

The purpose of the study is to investigate and compare the effects of three different versions of a future imaginal writing exercise (worst-case scenario, neutral future scenario, best-case scenario) for individuals with elevated social anxiety symptoms. Participants (estimated N=270) will be recruited through the online platform, Prolific, and will be randomly assigned to one of three writing exercise conditions. Participants will complete three study sessions across approximately three weeks. Study session 1 (T1) will consist of baseline assessments and pre-writing ratings, a future imaginal writing exercise, and then post-writing ratings. Study session 2 (T2) will occur approximately one week later and will consist of mid-study assessments and pre-writing ratings, a second, repeated future imaginal writing exercise, and then post-writing ratings. Finally, study session 3 (T3) will occur approximately one week later (approximately two weeks after T1) and will consist of follow-up assessments and repeated post-writing ratings.

Eligibility Criteria

Inclusion Criteria: * English fluency * Previous high-quality Prolific submission experience * Elevated social anxiety symptoms Exclusion Criteria: * Hospitalization for psychiatric reasons within the past year * Previous suicide attempt or self-harm * Previous treatment for severe head injury or past repeated serious head injury * Current psychosis symptoms * Elevated trauma symptoms

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07464158). StuddyBuddy aggregates publicly available trial information.